Literature DB >> 7515010

Differential removal of insulin-like growth factor binding proteins in rat serum by solvent extraction procedures.

K Srivenugopal1, S P Singh, X H Yuan, S Ehmann, A K Snyder.   

Abstract

Solvent extraction of serum and other biological fluids at an acidic pH is a convenient method to remove the insulin-like growth factor binding proteins (IGFBPs); however, an incomplete removal of IGFBPs can occur and this can potentially interfere with the radioimmunoassay of insulin-like growth factors (IGFs). This study compared the removal of IGFBPs from normal adult rat serum and 5-day old neonatal rat serum by acid-gel filtration, and three solvent extraction methods, i.e., acid-ethanol (AE), acid-cryo-ethanol (ACE) and formic acid-acetone (FAA) treatments by western ligand blotting and slot-blotting analysis. In adult rat serum all three extraction methods removed nearly 75% of total IGFBPs present. For the neonatal serum, AE and FAA were very inefficient in eliminating the IGFBPs, while ACE was somewhat better, as it removed nearly 30% of IGFBPs. Ligand blots of extracted samples showed that IGFBPs of lower size range, 24 to 32 kDa (IGFBP-4, IGFBPs-1 and -2), were resistant to solvent extraction. Acid-gel filtration, in contrast, eliminated > 95% of IGF-binding components in both sera. Determination of IGF-I concentrations in samples after gel filtration and extraction methods revealed lower IGF-I values in neonatal serum in acid extracted samples. These data caution against using solvent extractions for IGFBP removal in fetal/neonatal serum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515010     DOI: 10.1007/bf01920745

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  21 in total

Review 1.  Insulin-like growth factors and their binding proteins.

Authors:  V R Sara; K Hall
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

2.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; A J D'Ercole
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

3.  Failure of acid-ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factors.

Authors:  S Mesiano; I R Young; C A Browne; G D Thorburn
Journal:  J Endocrinol       Date:  1988-12       Impact factor: 4.286

4.  Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum.

Authors:  W H Daughaday; I K Mariz; S L Blethen
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

5.  Production of insulin-like growth factor I and its binding protein by adult rat hepatocytes in primary culture.

Authors:  C D Scott; J L Martin; R C Baxter
Journal:  Endocrinology       Date:  1985-03       Impact factor: 4.736

6.  Not all insulin-like growth factor-binding proteins (IGFBPs) are detectable by western ligand blotting: case studies of PC12 pheochromocytoma and rat anterior pituitary IGFBPs and proteolyzed IGFBP-3.

Authors:  I Ocrant; C T Fay; H Pham; R G Rosenfeld
Journal:  Endocrinology       Date:  1992-07       Impact factor: 4.736

7.  Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluids.

Authors:  R R Bowsher; W H Lee; J M Apathy; P J O'Brien; A L Ferguson; D P Henry
Journal:  Endocrinology       Date:  1991-02       Impact factor: 4.736

8.  A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I.

Authors:  W F Blum; M B Ranke; J R Bierich
Journal:  Acta Endocrinol (Copenh)       Date:  1988-07

9.  Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction.

Authors:  W H Daughaday; K A Parker; S Borowsky; B Trivedi; M Kapadia
Journal:  Endocrinology       Date:  1982-02       Impact factor: 4.736

10.  Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.

Authors:  J Zapf; H Walter; E R Froesch
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

View more
  4 in total

1.  Suppressor of cytokine signaling-2 gene disruption promotes Apc(Min/+) tumorigenesis and activator protein-1 activation.

Authors:  Victoria A Newton; Nicole M Ramocki; Brooks P Scull; James G Simmons; Kirk McNaughton; P Kay Lund
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

2.  The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice.

Authors:  Xue Gao; Yong-Hyun Shin; Min Li; Fei Wang; Qiang Tong; Pumin Zhang
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

3.  Obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon.

Authors:  M Agostina Santoro; R Eric Blue; Sarah F Andres; Amanda T Mah; Laurianne Van Landeghem; P Kay Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

4.  Impact of diet-induced obesity on intestinal stem cells: hyperproliferation but impaired intrinsic function that requires insulin/IGF1.

Authors:  Amanda T Mah; Laurianne Van Landeghem; Hannah E Gavin; Scott T Magness; P Kay Lund
Journal:  Endocrinology       Date:  2014-06-10       Impact factor: 4.736

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.